logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
29/08/2025
On Thursday, the South Korean won finally rose by 0.67% against the US dollar, closing at 1384.37 won, with continual fluctuation in an upward direction throughout the day.
Latest
2 m ago
CITIC Securities: Asset management policies support product innovation, with investor interests at the forefront.
3 m ago
CITIC Securities: Innovation in nuclear medicine RDC changes the paradigm of diagnosing and treating prostate cancer, opening up a new blue ocean market worth billions.
3 m ago
Citic Securities Research Report indicates that the innovative nuclear medicine RDC is expected to address the unsatisfied clinical needs in the diagnosis and treatment process of prostate cancer, such as the large burden of detection and limited efficacy, and change the paradigm of prostate cancer diagnosis and treatment, realizing integrated diagnosis and treatment, improving patient compliance and survival. Currently, there is no RDC listed in the Chinese market, presenting a blue ocean state. Overseas prostate cancer RDC diagnosis and treatment products are expected to enter the market in 2021 and approach a market size of nearly 3 billion USD by 2024, fully validating its enormous commercial value. We believe China is likely to replicate the development path of overseas prostate cancer RDC diagnosis and treatment market and predict that the future Chinese market for prostate cancer RDC diagnosis and treatment will exceed 10 billion RMB, showing a rapid growth trend. We believe that the key points in this industry are isotopes, ligand molecular forms, and production and distribution capabilities, and we recommend focusing on companies that have advantages in these conditions.
8 m ago
American version of "Huabei" Affirm surpasses expectations in Q4 performance, stock price soars after hours.
8 m ago
Caterpillar warns: Tariff impact expected to reach up to $1.8 billion this year
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.